Annual D&A
$677.00 K
+$41.00 K+6.45%
31 December 2023
Summary:
Verona Pharma annual depreciation & amortization is currently $677.00 thousand, with the most recent change of +$41.00 thousand (+6.45%) on 31 December 2023. During the last 3 years, it has risen by +$54.00 thousand (+8.67%). VRNA annual D&A is now at all-time high.VRNA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$266.00 K
-$4000.00-1.48%
30 September 2024
Summary:
Verona Pharma quarterly depreciation & amortization is currently $266.00 thousand, with the most recent change of -$4000.00 (-1.48%) on 30 September 2024. Over the past year, it has increased by +$111.00 thousand (+71.61%). VRNA quarterly D&A is now -1.48% below its all-time high of $270.00 thousand, reached on 30 June 2024.VRNA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.01 M
+$111.00 K+12.39%
30 September 2024
Summary:
Verona Pharma TTM depreciation & amortization is currently $1.01 million, with the most recent change of +$111.00 thousand (+12.39%) on 30 September 2024. Over the past year, it has increased by +$387.00 thousand (+62.42%). VRNA TTM D&A is now at all-time high.VRNA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.5% | +71.6% | +62.4% |
| 3 y3 years | +8.7% | +64.2% | +62.9% |
| 5 y5 years | +444.2% | +45.6% | +111.8% |
VRNA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +8.7% | -1.5% | +76.2% | at high | +62.9% |
| 5 y | 5 years | at high | +444.2% | -1.5% | +309.2% | at high | +111.8% |
| alltime | all time | at high | >+9999.0% | -1.5% | +1230.0% | at high | +4935.0% |
Verona Pharma Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $266.00 K(-1.5%) | $1.01 M(+12.4%) |
| June 2024 | - | $270.00 K(+2.7%) | $896.00 K(+14.4%) |
| Mar 2024 | - | $263.00 K(+26.4%) | $783.00 K(+15.7%) |
| Dec 2023 | $677.00 K(+6.4%) | $208.00 K(+34.2%) | $677.00 K(+9.2%) |
| Sept 2023 | - | $155.00 K(-1.3%) | $620.00 K(-0.3%) |
| June 2023 | - | $157.00 K(0.0%) | $622.00 K(-1.3%) |
| Mar 2023 | - | $157.00 K(+4.0%) | $630.00 K(-0.9%) |
| Dec 2022 | $636.00 K(+1.1%) | $151.00 K(-3.8%) | $636.00 K(-1.7%) |
| Sept 2022 | - | $157.00 K(-4.8%) | $647.00 K(-0.8%) |
| June 2022 | - | $165.00 K(+1.2%) | $652.00 K(+2.0%) |
| Mar 2022 | - | $163.00 K(+0.6%) | $639.00 K(+1.6%) |
| Dec 2021 | $629.00 K(+1.0%) | $162.00 K(0.0%) | $629.00 K(+1.8%) |
| Sept 2021 | - | $162.00 K(+6.6%) | $618.00 K(+0.8%) |
| June 2021 | - | $152.00 K(-0.7%) | $613.00 K(-0.5%) |
| Mar 2021 | - | $153.00 K(+1.3%) | $616.00 K(-1.1%) |
| Dec 2020 | $623.00 K(+22.2%) | $151.00 K(-3.8%) | $623.00 K(+16.0%) |
| Sept 2020 | - | $157.00 K(+1.3%) | $537.00 K(-4.6%) |
| June 2020 | - | $155.00 K(-3.1%) | $562.70 K(+4.8%) |
| Mar 2020 | - | $160.00 K(+146.2%) | $537.00 K(+5.3%) |
| Dec 2019 | $510.00 K | $65.00 K(-64.4%) | $510.00 K(+7.3%) |
| Sept 2019 | - | $182.70 K(+41.3%) | $475.50 K(+46.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $129.30 K(-2.8%) | $325.20 K(+44.5%) |
| Mar 2019 | - | $133.00 K(+336.1%) | $225.10 K(+81.1%) |
| Dec 2018 | $124.40 K(-25.2%) | $30.50 K(-5.9%) | $124.30 K(-33.3%) |
| Sept 2018 | - | $32.40 K(+11.0%) | $186.30 K(+2.4%) |
| June 2018 | - | $29.20 K(-9.3%) | $182.00 K(+2.0%) |
| Mar 2018 | - | $32.20 K(-65.2%) | $178.40 K(+7.3%) |
| Dec 2017 | $166.20 K(+117.3%) | $92.50 K(+229.2%) | $166.20 K(+125.5%) |
| Sept 2017 | - | $28.10 K(+9.8%) | $73.70 K(+61.6%) |
| June 2017 | - | $25.60 K(+28.0%) | $45.60 K(+128.0%) |
| Mar 2017 | - | $20.00 K | $20.00 K |
| Dec 2016 | $76.50 K(-2.5%) | - | - |
| Dec 2015 | $78.50 K(-4.7%) | - | - |
| Dec 2014 | $82.40 K(+32.9%) | - | - |
| Dec 2013 | $62.00 K(+26.3%) | - | - |
| Dec 2012 | $49.10 K(+35.3%) | - | - |
| Dec 2011 | $36.30 K(+12.0%) | - | - |
| Dec 2010 | $32.40 K(-9.0%) | - | - |
| Dec 2009 | $35.60 K(+28.1%) | - | - |
| Dec 2008 | $27.80 K(+7.8%) | - | - |
| Dec 2007 | $25.80 K(+561.5%) | - | - |
| Dec 2006 | $3900.00 | - | - |
FAQ
- What is Verona Pharma annual depreciation & amortization?
- What is the all time high annual D&A for Verona Pharma?
- What is Verona Pharma annual D&A year-on-year change?
- What is Verona Pharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Verona Pharma?
- What is Verona Pharma quarterly D&A year-on-year change?
- What is Verona Pharma TTM depreciation & amortization?
- What is the all time high TTM D&A for Verona Pharma?
- What is Verona Pharma TTM D&A year-on-year change?
What is Verona Pharma annual depreciation & amortization?
The current annual D&A of VRNA is $677.00 K
What is the all time high annual D&A for Verona Pharma?
Verona Pharma all-time high annual depreciation & amortization is $677.00 K
What is Verona Pharma annual D&A year-on-year change?
Over the past year, VRNA annual depreciation & amortization has changed by +$41.00 K (+6.45%)
What is Verona Pharma quarterly depreciation & amortization?
The current quarterly D&A of VRNA is $266.00 K
What is the all time high quarterly D&A for Verona Pharma?
Verona Pharma all-time high quarterly depreciation & amortization is $270.00 K
What is Verona Pharma quarterly D&A year-on-year change?
Over the past year, VRNA quarterly depreciation & amortization has changed by +$111.00 K (+71.61%)
What is Verona Pharma TTM depreciation & amortization?
The current TTM D&A of VRNA is $1.01 M
What is the all time high TTM D&A for Verona Pharma?
Verona Pharma all-time high TTM depreciation & amortization is $1.01 M
What is Verona Pharma TTM D&A year-on-year change?
Over the past year, VRNA TTM depreciation & amortization has changed by +$387.00 K (+62.42%)